Global Hiatal Hernia Treatment Market - Industry Trends and Forecast to 2028

Market Analysis and Insights : Global Hiatal Hernia Treatment Market

Hiatal hernia treatment market is expected to gain market growth in the forecast period of 2021-2028. Data Bridge Market Research analyses the market to account to grow at a CAGR of 6.50% in the above mentioned forecast period.

A hernia occurs when a portion of an organ protrudes through a hole in the muscular wall that surrounds it. Part of your stomach pushes up into an opening (known as hiatus) in your diaphragm in a hiatal hernia. The diaphragm is a muscle that connects your stomach (abdomen) to your chest. Sliding and paraesophageal hiatal hernias are the two most common forms. Hiatal hernia is digestive disorder characterized by regurgitation of food or liquids into the mouth, heartburn, backflow of stomach acid into the esophagus, chest or abdominal pain, difficulty swallowing, feeling full soon after you eat, shortness of breath, gastrointestinal bleeding and vomiting.

The rise in the prevalence of hiatal hernia treatment and rising healthcare expenditure are the major factors influencing the market growth rate. Furthermore, increasing geriatric population, growing government funding and rising initiatives by public and private organisations to spread awareness about the disease and its available treatment are the factors that will expand the hiatal hernia treatment market. Other factors including growing incidences of obesity, smoking, alcohol abuse and changing lifestyle will positively impact the market growth rate.

Rise in the research and development activities and emerging new markets will provide beneficial opportunities for the hiatal hernia treatment market in the forecast period of 2021-2028.

However, high cost of the treatment and complications associated with the disease such as pulmonary aspiration, slow bleeding and iron deficiency anaemia are the factors that will hinder the market growth. Lack of awareness about the preventive options will further challenge the hiatal hernia treatment market in the forecast period mentioned above.

This hiatal hernia treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the hiatal hernia treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Hiatal Hernia Treatment Market Scope and Market Size

The hiatal hernia treatment market is segmented on the basis of type, treatment, diagnosis, symptoms, dosage, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of type, the hiatal hernia treatment market is segmented into sliding hiatal hernia and paraesophageal hiatal hernia.
• On the basis of treatment, the hiatal hernia treatment market is segmented into medication, surgery, diet and others. The medication segment is further sub-segmented into antacids, proton pump inhibitors, H2-receptor blockers and others.
• On the basis of diagnosis, the hiatal hernia treatment market is segmented into esophagogastroduodenoscopy, chest x-ray, esophageal manometry and upper GI (gastrointestinal) series.
• On the basis of symptoms, the hiatal hernia treatment market is segmented into regurgitation of food or liquids into the mouth, heartburn, backflow of stomach acid into the esophagus, chest or abdominal pain, difficulty swallowing, feeling full soon after you eat, shortness of breath, gastrointestinal bleeding, vomiting, and others.
• On the basis of dosage, the hiatal hernia treatment market is segmented into tablet, injection and others.
• On the basis of route of administration, the hiatal hernia treatment market is segmented into oral, intravenous and others.
• On the basis of end-users, the hiatal hernia treatment market is segmented into clinic, hospital and others.
• The hiatal hernia treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Hiatal Hernia Treatment Market Country Level Analysis

Hiatal hernia treatment market is analyzed and market size information is provided by the country, type, treatment, diagnosis, symptoms, dosage, route of administration, end-users and distribution channel as referenced above.

The countries covered in the hiatal hernia treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the hiatal hernia treatment market due to the rising awareness about diseases, health related problems arising due to presence of major key players, high disposable income and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising investment in the healthcare sector and growing government support.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Hiatal hernia treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Hiatal Hernia Treatment Market Share Analysis

Hiatal hernia treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to hiatal hernia treatment market research.

The major players covered in the hiatal hernia treatment market report are Boehringer Ingelheim International GmbH., GlaxoSmithKline plc, Bayer AG, Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited., Dr. Reddy’s Laboratories Ltd., Procter & Gamble, Reckitt Benckiser Group PLC, Johnson & Johnson Private Limited, Perrigo Company plc, Mylan N.V., Aurobindo Pharma, Abbott, AstraZeneca, Novartis AG, among other domestic and global players.  Market share data is available for Global, North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

SKU-67128